BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29761831)

  • 21. PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Visco C; Contino L; Ciccone G; Ladetto M
    Thromb Res; 2016 Apr; 140 Suppl 1():S177. PubMed ID: 27161692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism in patients with diffuse large B-cell lymphoma.
    Komrokji RS; Uppal NP; Khorana AA; Lyman GH; Kaplan KL; Fisher RI; Francis CW
    Leuk Lymphoma; 2006 Jun; 47(6):1029-33. PubMed ID: 16840193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
    Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
    Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
    [No Abstract]   [Full Text] [Related]  

  • 26. Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: A retrospective case control study.
    Li H; Tian Y; Niu H; He L; Cao G; Zhang C; Kaiweisierkezi K; Luo Q
    Front Oncol; 2022; 12():988287. PubMed ID: 36300098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.
    Park LC; Woo SY; Kim S; Jeon H; Ko YH; Kim SJ; Kim WS
    Thromb Res; 2012 Sep; 130(3):e6-12. PubMed ID: 22507288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
    Li S; Gao P; Qiu J; He X; Mao Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction Model of in-Hospital Venous Thromboembolism in Chinese Adult Patients after Hernia Surgery: The CHAT Score.
    Gu ZC; Zhang C; Yang Y; Wang MG; Li HY; Zhang GY
    Clin Appl Thromb Hemost; 2021; 27():10760296211051704. PubMed ID: 34928746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients.
    Otasevic V; Mihaljevic B; Milic N; Stanisavljevic D; Vukovic V; Tomic K; Fareed J; Antic D
    Thromb J; 2022 Apr; 20(1):20. PubMed ID: 35439998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden.
    Schönning A; Karlén J; Frisk T; Heyman M; Svahn JE; Øra I; Kawan L; Holmqvist BM; Björklund C; Harila-Saari A; Ranta S
    Thromb Res; 2017 Apr; 152():64-68. PubMed ID: 28249199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.
    Thaler J; Ay C; Kaider A; Reitter EM; Haselböck J; Mannhalter C; Zielinski C; Marosi C; Pabinger I
    Neuro Oncol; 2014 Dec; 16(12):1645-51. PubMed ID: 24987133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
    Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features.
    Lan Y; Guan J; Zhu J; Wang J; Li M; Sun C; Sun F; Huang J; Lu S; Zhang Y
    Leuk Res; 2021 Apr; 103():106537. PubMed ID: 33631621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
    Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
    JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma.
    Borg IH; Bendtsen MD; Bøgsted M; Madsen J; Severinsen MT
    Leuk Lymphoma; 2016 Dec; 57(12):2771-2776. PubMed ID: 27266904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High incidence of thromboembolism in patients with central nervous system lymphoma.
    Goldschmidt N; Linetsky E; Shalom E; Varon D; Siegal T
    Cancer; 2003 Sep; 98(6):1239-42. PubMed ID: 12973848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphoma and venous thromboembolism: influence on mortality.
    Mahajan A; Wun T; Chew H; White RH
    Thromb Res; 2014 May; 133 Suppl 2():S23-8. PubMed ID: 24862141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer.
    Gerotziafas GT; Mahé I; Lefkou E; AboElnazar E; Abdel-Razeq H; Taher A; Antic D; Elalamy I; Syrigos K; Van Dreden P
    Thromb Res; 2020 Jul; 191 Suppl 1():S50-S57. PubMed ID: 32736779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.